In a 65-year-old man with three-month worsening dyspnea, dry cough, 50-pack-year smoking history, hand and knee arthritis, taking lisinopril, atorvastatin, and naproxen, oxygen saturation 92% on room air, basal crackles, and osteophytic changes of the proximal and distal interphalangeal joints, which diagnostic test is most appropriate next: hypersensitivity pneumonitis panel, transthoracic echocardiogram, high-resolution computed tomography (HRCT) of the chest, or surgical lung biopsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

High-Resolution CT Scan of the Chest

In this 65-year-old man with progressive dyspnea, bibasilar crackles, significant smoking history, and osteoarthritis, high-resolution CT (HRCT) of the chest is the most appropriate next diagnostic test. 1

Rationale for HRCT as the Initial Test

The clinical presentation—three months of worsening dyspnea, nonproductive cough, bibasilar crackles, hypoxemia (92% on room air), and significant smoking history (50 pack-years)—strongly suggests interstitial lung disease (ILD), most likely idiopathic pulmonary fibrosis (IPF) given the age, smoking history, and clinical features. 1

HRCT is essential for characterizing the pattern of ILD and establishing diagnostic confidence before proceeding to more invasive testing. 1 The American Thoracic Society/European Respiratory Society guidelines emphasize that HRCT patterns can establish a definite diagnosis of IPF when a usual interstitial pneumonia (UIP) pattern is present, eliminating the need for surgical lung biopsy in many cases. 1

Key HRCT Findings to Assess

  • UIP pattern (subpleural/basal predominant reticular abnormality with honeycombing ± traction bronchiectasis) would support IPF diagnosis without requiring biopsy 1
  • Probable UIP or indeterminate patterns would guide decisions about bronchoalveolar lavage (BAL) or surgical lung biopsy 1
  • Alternative diagnoses such as hypersensitivity pneumonitis (centrilobular nodules, mosaic attenuation, air trapping) or connective tissue disease-related ILD would redirect the diagnostic workup 1

Why Other Tests Are Not Appropriate Now

Hypersensitivity Pneumonitis Panel

A hypersensitivity pneumonitis (HP) panel should not be ordered before HRCT imaging. 1 While HP is in the differential diagnosis, the clinical presentation (older age, smoking history, bibasilar crackles without upper/mid-lung findings) makes fibrotic HP or IPF more likely than acute HP. 1 The 2021 CHEST guideline emphasizes that HRCT patterns must be evaluated first to determine diagnostic confidence for HP, as typical HP patterns include centrilobular nodules, mosaic attenuation, and air trapping—features not yet documented in this patient. 1

Transthoracic Echocardiogram

Echocardiography is not the appropriate initial test for this presentation. 1 While the patient takes lisinopril (suggesting possible cardiovascular history), the absence of jugular venous distension, peripheral edema, and the presence of bibasilar crackles with hypoxemia point toward parenchymal lung disease rather than heart failure. 1 Echocardiography may be appropriate later to assess for pulmonary hypertension as a complication of ILD, but HRCT must establish the presence and pattern of ILD first. 1

Surgical Lung Biopsy

Surgical lung biopsy (SLB) should not be performed before HRCT imaging. 1 The ATS/ERS/JRS/ALAT 2018 guidelines provide a strong recommendation against performing SLB in patients with suspected IPF who have an HRCT pattern of UIP (strong recommendation, very low quality of evidence). 1 SLB carries significant risks of complications, particularly in patients with severe hypoxemia or diffusion capacity <25% predicted. 1 HRCT must be obtained first to determine whether the pattern is diagnostic for UIP (making biopsy unnecessary) or whether biopsy would add diagnostic value. 1

Diagnostic Algorithm After HRCT

Once HRCT is obtained, the diagnostic pathway depends on the imaging pattern:

  • If UIP pattern is present: Diagnosis of IPF can be made without biopsy if clinical context is appropriate (age >60 years, progressive dyspnea, bibasilar crackles, no alternative cause identified). 1

  • If probable UIP, indeterminate, or alternative pattern: Consider BAL to assess lymphocytosis (>30% suggests HP over IPF) and potentially transbronchial biopsy or surgical lung biopsy depending on diagnostic confidence and surgical risk. 1

  • If features suggest HP: Pursue detailed exposure history (birds, mold, occupational antigens), serum IgG antibodies to specific antigens, and consider BAL with lymphocyte differential. 1

  • If features suggest connective tissue disease-related ILD: Evaluate for systemic autoimmune rheumatic diseases with appropriate serologic testing and rheumatology consultation. 1

Common Pitfalls to Avoid

  • Do not delay HRCT in favor of less specific tests. The ACR Appropriateness Criteria emphasize that HRCT with thin collimation (≤1 mm slices) is essential for characterizing chronic dyspnea when ILD is suspected. 1

  • Do not proceed directly to surgical lung biopsy without HRCT. Many patients with UIP pattern on HRCT do not require biopsy, and biopsy carries significant morbidity and mortality risks. 1

  • Do not assume heart failure based solely on medication history. The clinical presentation (bibasilar crackles without edema or JVD, hypoxemia, nonproductive cough) is more consistent with ILD than cardiac disease. 1

  • Do not overlook drug-induced ILD. While naproxen is not a common cause of ILD, NSAIDs can rarely cause pulmonary toxicity; HRCT patterns would help distinguish this from other etiologies. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.